Research study Program year 2025 Source: CMS Open Payments

A Phase 1 Study of Sgnpdl1v in Advanced Solid Tumors

Research payments

$6,566,666

242 payments

Through program year 2025, $6,566,666 in research payments was reported against A Phase 1 Study of Sgnpdl1v in Advanced Solid Tumors, across 242 payments, paid by Pfizer Inc..

Paid by
Pfizer Inc.
ClinicalTrials.gov
No trial number was reported for this study

By program year

2 rows
Year Kind Amount Payments
2025 Research $3,799,658 122
2024 Research $2,767,009 120

Breakdown

Who paid Research payments · program years 2024–2025
  1. Pfizer Inc. $6,566,666 242 payments
Who received the money Research payments · program years 2024–2025
  1. Ut Md Anderson Cancer Center Teaching hospital · TX $3,734,818 23 payments
  2. University Of Alabama Hospital Teaching hospital · AL $1,311,299 69 payments
  3. Uh Cleveland Medical Center Teaching hospital · OH $475,768 9 payments
  4. Karmanos Cancer Hospital Teaching hospital · MI $260,549 51 payments
  5. University Of Iowa Hosp & Clinics Teaching hospital · IA $240,206 13 payments
  6. Uc Davis Medical Center Teaching hospital · CA $179,520 13 payments
  7. Start Mountain Region Organisation paid for research $90,745 15 payments
  8. Karmanos Cancer Institute Organisation paid for research $73,902 18 payments
  9. Rainbow Babies & Childrens Hospita Teaching hospital · OH $58,710 9 payments
  10. Start Center For Cancer Care Organisation paid for research $54,504 6 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

6 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record